Expression of Concern: HTLV-1 tax mediated downregulation of miRNAs associated with chromatin remodeling factors in T cells with stably integrated viral promoter (PLoS ONE (2012) 7: 4 (e34490) DOI: 10.1371/journal.pone.0034490);HTLV-1 tax mediated downregulation of miRNAs associated with chromatin remodeling factors in T cells with stably integrated viral promoter

PLoS ONE

Volumn 7, Issue 4, 2012, Pages

  Rahman, Saifur ^a   Quann, Kevin ^a   Pandya, Devanshi ^a   Singh, Shruti ^a   Khan, Zafar K ^a   Jain, Pooja ^a  

^a DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA; MICRORNA 149; MICRORNA 873; PROTEIN P300; TAX PROTEIN; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG; HISTONE ACETYLTRANSFERASE PCAF; LUCIFERASE; MESSENGER RNA; P300-CBP-ASSOCIATED FACTOR; TAX PROTEIN, HUMAN T LYMPHOTROPHIC VIRUS 1; TAX PROTEIN, HUMAN T-LYMPHOTROPHIC VIRUS 1;

ARTICLE; BIOINFORMATICS; CD4+ T LYMPHOCYTE; CELL CLONE; CHROMATIN ASSEMBLY AND DISASSEMBLY; CHROMOSOME; CONTROLLED STUDY; DOWN REGULATION; GENE EXPRESSION REGULATION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN T CELL LEUKEMIA VIRUS 1; LONG TERMINAL REPEAT; MICROARRAY ANALYSIS; NONHUMAN; PATHOGENESIS; PROMOTER REGION; RNA INTERFERENCE; RNA VIRUS INFECTION; TRANSLATION REGULATION; VIRUS CELL INTERACTION; CYTOLOGY; GENETIC TRANSCRIPTION; GENETICS; METABOLISM; REAL TIME POLYMERASE CHAIN REACTION; REGULATORY SEQUENCE; RETROVIRUS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SOUTHERN BLOTTING; T LYMPHOCYTE; TRANSCRIPTION INITIATION; WESTERN BLOTTING;

HUMAN T-LYMPHOTROPIC VIRUS 1;

BLOTTING, SOUTHERN; BLOTTING, WESTERN; CHROMATIN ASSEMBLY AND DISASSEMBLY; DOWN-REGULATION; GENE EXPRESSION REGULATION; GENE PRODUCTS, TAX; HUMANS; LUCIFERASES; MICRORNAS; P300-CBP TRANSCRIPTION FACTORS; PROMOTER REGIONS, GENETIC; REAL-TIME POLYMERASE CHAIN REACTION; REGULATORY SEQUENCES, NUCLEIC ACID; RETROVIRIDAE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; T-LYMPHOCYTES; TERMINAL REPEAT SEQUENCES; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC; TRANSCRIPTIONAL ACTIVATION;

EID: 84859346742     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0229498     Document Type: Erratum

References (87)

1. Poiesz BJ, Ruscetti FW, Gazdar AF, Bunn PA, Minna JD, et al. (1980) Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma. Proc Natl Acad Sci U S A 77: 7415-7419.
2. Gallo RC, (2005) The discovery of the first human retrovirus: HTLV-1 and HTLV-2. Retrovirology 2: 17.
3. Takatsuki K, (2005) Discovery of adult T-cell leukemia. Retrovirology 2: 16.
4. Palutke M, Patt DJ, Weise R, Varadachari C, Wylin RF, et al. (1977) T cell leukemia-lymphoma in young adults. Am J Clin Pathol 68: 429-439.
5. Gessain A, Barin F, Vernant JC, Gout O, Maurs L, et al. (1985) Antibodies to human T-lymphotropic virus type-I in patients with tropical spastic paraparesis. Lancet 2: 407-410.
6. Osame M, Usuku K, Izumo S, Ijichi N, Amitani H, et al. (1986) HTLV-I associated myelopathy, a new clinical entity. Lancet 1: 1031-1032.
7. Edlich RF, Arnette JA, Williams FM, (2000) Global epidemic of human T-cell lymphotropic virus type-I (HTLV-I). J Emerg Med 18: 109-119.
8. Uchiyama T, (1997) Human T cell leukemia virus type I (HTLV-I) and human diseases. Annu Rev Immunol 15: 15-37.
9. Schechter GP, Whang-Peng J, McFarland W, (1977) Circulation of donor lymphocytes after blood transfusion in man. Blood 49: 651-656.
10. Hayashi D, Kubota R, Takenouchi N, Nakamura T, Umehara F, et al. (2008) Accumulation of human T-lymphotropic virus type I (HTLV-I)-infected cells in the cerebrospinal fluid during the exacerbation of HTLV-I-associated myelopathy. J Neurovirol 14: 459-463.
11. Bangham CR, (2003) The immune control and cell-to-cell spread of human T-lymphotropic virus type 1. J Gen Virol 84: 3177-3189.
12. Newbound GC, Andrews JM, O'Rourke JP, Brady JN, Lairmore MD, (1996) Human T-cell lymphotropic virus type 1 Tax mediates enhanced transcription in CD4+ T lymphocytes. J Virol 70: 2101-2106.
13. Nagai M, Brennan MB, Sakai JA, Mora CA, Jacobson S, (2001) CD8(+) T cells are an in vivo reservoir for human T-cell lymphotropic virus type I. Blood 98: 1858-1861.
14. Grant C, Barmak K, Alefantis T, Yao J, Jacobson S, et al. (2002) Human T cell leukemia virus type I and neurologic disease: events in bone marrow, peripheral blood, and central nervous system during normal immune surveillance and neuroinflammation. J Cell Physiol 190: 133-159.
15. Jones KS, Petrow-Sadowski C, Huang YK, Bertolette DC, Ruscetti FW, (2008) Cell-free HTLV-1 infects dendritic cells leading to transmission and transformation of CD4(+) T cells. Nat Med 14: 429-436.
16. Lehky TJ, Fox CH, Koenig S, Levin MC, Flerlage N, et al. (1995) Detection of human T-lymphotropic virus type I (HTLV-I) tax RNA in the central nervous system of HTLV-I-associated myelopathy/tropical spastic paraparesis patients by in situ hybridization. Ann Neurol 37: 167-175.
17. Doi K, Wu X, Taniguchi Y, Yasunaga J, Satou Y, et al. (2005) Preferential selection of human T-cell leukemia virus type I provirus integration sites in leukemic versus carrier states. Blood 106: 1048-1053.
18. Elgin SC, (1990) Chromatin structure and gene activity. Curr Opin Cell Biol 2: 437-445.
19. Igakura T, Stinchcombe JC, Goon PK, Taylor GP, Weber JN, et al. (2003) Spread of HTLV-I between lymphocytes by virus-induced polarization of the cytoskeleton. Science 299: 1713-1716.
20. Pais-Correia AM, Sachse M, Guadagnini S, Robbiati V, Lasserre R, et al. (2010) Biofilm-like extracellular viral assemblies mediate HTLV-1 cell-to-cell transmission at virological synapses. Nat Med 16: 83-89.
21. Kiyokawa T, Seiki M, Imagawa K, Shimizu F, Yoshida M, (1984) Identification of a protein (p40x) encoded by a unique sequence pX of human T-cell leukemia virus type I. Gann 75: 747-751.
22. Sodroski JG, Rosen CA, Haseltine WA, (1984) Trans-acting transcriptional activation of the long terminal repeat of human T lymphotropic viruses in infected cells. Science 225: 381-385.
23. Pandya D, Rahman S, Wigdahl B, Khan ZK, Jain P, (2007) New insights into the pathogenesis, diagnosis and treatment of human T-cell leukemia virus type 1-induced disease. Future Virology 2: 481-493.
24. Matsuoka M, Jeang KT, (2007) Human T-cell leukaemia virus type 1 (HTLV-1) infectivity and cellular transformation. Nat Rev Cancer 7: 270-280.
25. Beimling P, Moelling K, (1992) Direct interaction of CREB protein with 21 bp Tax-response elements of HTLV-ILTR. Oncogene 7: 257-262.
26. Paca-Uccaralertkun S, Zhao LJ, Adya N, Cross JV, Cullen BR, et al. (1994) In vitro selection of DNA elements highly responsive to the human T-cell lymphotropic virus type I transcriptional activator, Tax. Mol Cell Biol 14: 456-462.
27. Zhao LJ, Giam CZ, (1992) Human T-cell lymphotropic virus type I (HTLV-I) transcriptional activator, Tax, enhances CREB binding to HTLV-I 21-base-pair repeats by protein-protein interaction. Proc Natl Acad Sci U S A 89: 7070-7074.
28. Barnhart MK, Connor LM, Marriott SJ, (1997) Function of the human T-cell leukemia virus type 1 21-base-pair repeats in basal transcription. J Virol 71: 337-344.
29. Lenzmeier BA, Giebler HA, Nyborg JK, (1998) Human T-cell leukemia virus type 1 Tax requires direct access to DNA for recruitment of CREB binding protein to the viral promoter. Mol Cell Biol 18: 721-731.
30. Adya N, Giam CZ, (1995) Distinct regions in human T-cell lymphotropic virus type I tax mediate interactions with activator protein CREB and basal transcription factors. J Virol 69: 1834-1841.
31. Suzuki T, Hirai H, Fujisawa J, Fujita T, Yoshida M, (1993) A trans-activator Tax of human T-cell leukemia virus type 1 binds to NF-kappa B p50 and serum response factor (SRF) and associates with enhancer DNAs of the NF-kappa B site and CArG box. Oncogene 8: 2391-2397.
32. Azran I, Schavinsky-Khrapunsky Y, Aboud M, (2004) Role of Tax protein in human T-cell leukemia virus type-I leukemogenicity. Retrovirology 1: 20.
33. Harrod R, Kuo YL, Tang Y, Yao Y, Vassilev A, et al. (2000) p300 and p300/cAMP-responsive element-binding protein associated factor interact with human T-cell lymphotropic virus type-1 Tax in a multi-histone acetyltransferase/activator-enhancer complex. J Biol Chem 275: 11852-11857.
34. Harrod R, Tang Y, Nicot C, Lu HS, Vassilev A, et al. (1998) An exposed KID-like domain in human T-cell lymphotropic virus type 1 Tax is responsible for the recruitment of coactivators CBP/p300. Mol Cell Biol 18: 5052-5061.
35. Tie F, Adya N, Greene WC, Giam CZ, (1996) Interaction of the human T-lymphotropic virus type 1 Tax dimer with CREB and the viral 21-base-pair repeat. J Virol 70: 8368-8374.
36. Jiang H, Lu H, Schiltz RL, Pise-Masison CA, Ogryzko VV, et al. (1999) PCAF interacts with tax and stimulates tax transactivation in a histone acetyltransferase-independent manner. Mol Cell Biol 19: 8136-8145.
37. Bogenberger JM, Laybourn PJ, (2008) Human T Lymphotropic Virus Type 1 protein Tax reduces histone levels. Retrovirology 5: 9.
38. Easley R, Carpio L, Guendel I, Klase Z, Choi S, et al. (2010) Human T-lymphotropic virus type 1 transcription and chromatin-remodeling complexes. J Virol 84: 4755-4768.
39. Kwok RP, Laurance ME, Lundblad JR, Goldman PS, Shih H, et al. (1996) Control of cAMP-regulated enhancers by the viral transactivator Tax through CREB and the co-activator CBP. Nature 380: 642-646.
40. Bantignies F, Rousset R, Desbois C, Jalinot P, (1996) Genetic characterization of transactivation of the human T-cell leukemia virus type 1 promoter: Binding of Tax to Tax-responsive element 1 is mediated by the cyclic AMP-responsive members of the CREB/ATF family of transcription factors. Mol Cell Biol 16: 2174-2182.
41. Bodor J, Walker W, Flemington E, Spetz AL, Habener JF, (1995) Modulation of Tax and PKA-mediated expression of HTLV-I promoter via cAMP response element binding and modulator proteins CREB and CREM. FEBS Lett 377: 413-418.
42. Kashanchi F, Duvall JF, Kwok RP, Lundblad JR, Goodman RH, et al. (1998) The coactivator CBP stimulates human T-cell lymphotrophic virus type I Tax transactivation in vitro. J Biol Chem 273: 34646-34652.
43. Scoggin KE, Ulloa A, Nyborg JK, (2001) The oncoprotein Tax binds the SRC-1-interacting domain of CBP/p300 to mediate transcriptional activation. Mol Cell Biol 21: 5520-5530.
44. El Kharroubi A, Piras G, Zensen R, Martin MA, (1998) Transcriptional activation of the integrated chromatin-associated human immunodeficiency virus type 1 promoter. Mol Cell Biol 18: 2535-2544.
45. Benkirane M, Chun RF, Xiao H, Ogryzko VV, Howard BH, et al. (1998) Activation of integrated provirus requires histone acetyltransferase. p300 and P/CAF are coactivators for HIV-1 Tat. J Biol Chem 273: 24898-24905.
46. Hollsberg P, Hafler DA, (1993) Seminars in medicine of the Beth Israel Hospital, Boston. Pathogenesis of diseases induced by human lymphotropic virus type I infection. N Engl J Med 328: 1173-1182.
47. Marzio G, Verhoef K, Vink M, Berkhout B, (2001) In vitro evolution of a highly replicating, doxycycline-dependent HIV for applications in vaccine studies. Proc Natl Acad Sci U S A 98: 6342-6347.
48. Rossi C, Gibellini D, Barbanti-Brodano G, Betti M, Boarini C, et al. (1999) Transiently transfected and stably integrated HIV-1 LTR responds differentially to the silencing activity of the Kruppel-associated box (KRAB) transcriptional repressor domain. J Med Virol 58: 264-272.
49. Okada M, Jeang KT, (2002) Differential requirements for activation of integrated and transiently transfected human T-cell leukemia virus type 1 long terminal repeat. J Virol 76: 12564-12573.
50. Tateno M, Kondo N, Itoh T, Chubachi T, Togashi T, et al. (1984) Rat lymphoid cell lines with human T cell leukemia virus production. I. Biological and serological characterization. J Exp Med 159: 1105-1116.
51. Grant C, Jain P, Nonnemacher M, Flaig KE, Irish B, et al. (2006) AP-1-directed human T cell leukemia virus type 1 viral gene expression during monocytic differentiation. J Leukoc Biol 80: 640-650.
52. Nagai M, Usuku K, Matsumoto W, Kodama D, Takenouchi N, et al. (1998) Analysis of HTLV-I proviral load in 202 HAM/TSP patients and 243 asymptomatic HTLV-I carriers: high proviral load strongly predisposes to HAM/TSP. J Neurovirol 4: 586-593.
53. Quivy V, De Walque S, Van Lint C, (2007) Chromatin-associated regulation of HIV-1 transcription: implications for the development of therapeutic strategies. Subcell Biochem 41: 371-396.
54. Derse D, Crise B, Li Y, Princler G, Lum N, et al. (2007) Human T-cell leukemia virus type 1 integration target sites in the human genome: comparison with those of other retroviruses. J Virol 81: 6731-6741.
55. Meekings KN, Leipzig J, Bushman FD, Taylor GP, Bangham CR, (2008) HTLV-1 integration into transcriptionally active genomic regions is associated with proviral expression and with HAM/TSP. PLoS Pathog 4: e1000027.
56. Waziri A, Soldan SS, Graf MD, Nagle J, Jacobson S, (2000) Characterization and sequencing of prototypic human T-lymphotropic virus type 1 (HTLV-1) from an HTLV-1/2 seroindeterminate patient. J Virol 74: 2178-2185.
57. Richardson JH, Hollsberg P, Windhagen A, Child LA, Hafler DA, et al. (1997) Variable immortalizing potential and frequent virus latency in blood-derived T-cell clones infected with human T-cell leukemia virus type I. Blood 89: 3303-3314.
58. Ureta-Vidal A, Pique C, Garcia Z, Dehee A, Tortevoye P, et al. (2001) Human T cell leukemia virus Type I (HTLV-I) infection induces greater expansions of CD8 T lymphocytes in persons with HTLV-I-associated myelopathy/tropical spastic paraparesis than in asymptomatic carriers. J Infect Dis 183: 857-864.
59. Silva MT, Harab RC, Leite AC, Schor D, Araujo A, et al. (2007) Human T lymphotropic virus type 1 (HTLV-1) proviral load in asymptomatic carriers, HTLV-1-associated myelopathy/tropical spastic paraparesis, and other neurological abnormalities associated with HTLV-1 infection. Clin Infect Dis 44: 689-692.
60. Shinzato O, Ikeda S, Momita S, Nagata Y, Kamihira S, et al. (1991) Semiquantitative analysis of integrated genomes of human T-lymphotropic virus type I in asymptomatic virus carriers. Blood 78: 2082-2088.
61. Triboulet R, Mari B, Lin YL, Chable-Bessia C, Bennasser Y, et al. (2007) Suppression of microRNA-silencing pathway by HIV-1 during virus replication. Science 315: 1579-1582.
62. Rusinov V, Baev V, Minkov IN, Tabler M, (2005) MicroInspector: a web tool for detection of miRNA binding sites in an RNA sequence. Nucleic Acids Res 33: W696-700.
63. Persaud D, Zhou Y, Siliciano JM, Siliciano RF, (2003) Latency in human immunodeficiency virus type 1 infection: no easy answers. J Virol 77: 1659-1665.
64. Cullen BR, (2006) Viruses and microRNAs. Nat Genet 38 (Suppl): S25-30.
65. Kishimoto M, Fujiki R, Takezawa S, Sasaki Y, Nakamura T, et al. (2006) Nuclear receptor mediated gene regulation through chromatin remodeling and histone modifications. Endocr J 53: 157-172.
66. Doucas V, Evans RM, (1999) Human T-cell leukemia retrovirus-Tax protein is a repressor of nuclear receptor signaling. Proc Natl Acad Sci U S A 96: 2633-2638.
67. Belandia B, Parker MG, (2003) Nuclear receptors: a rendezvous for chromatin remodeling factors. Cell 114: 277-280.
68. Koszewski NJ, Henry KW, Lubert EJ, Gravatte H, Noonan DJ, (2003) Use of a modified yeast one-hybrid screen to identify BAF60a interactions with the Vitamin D receptor heterodimer. J Steroid Biochem Mol Biol 87: 223-231.
69. Nie Z, Xue Y, Yang D, Zhou S, Deroo BJ, et al. (2000) A specificity and targeting subunit of a human SWI/SNF family-related chromatin-remodeling complex. Mol Cell Biol 20: 8879-8888.
70. Bartel DP, (2004) MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116: 281-297.
71. Lecellier CH, Dunoyer P, Arar K, Lehmann-Che J, Eyquem S, et al. (2005) A cellular microRNA mediates antiviral defense in human cells. Science 308: 557-560.
72. Bennasser Y, Le SY, Yeung ML, Jeang KT, (2004) HIV-1 encoded candidate micro-RNAs and their cellular targets. Retrovirology 1: 43.
73. Yeung ML, Bennasser Y, Myers TG, Jiang G, Benkirane M, et al. (2005) Changes in microRNA expression profiles in HIV-1-transfected human cells. Retrovirology 2: 81.
74. Hakim ST, Alsayari M, McLean DC, Saleem S, Addanki KC, et al. (2008) A large number of the human microRNAs target lentiviruses, retroviruses, and endogenous retroviruses. Biochem Biophys Res Commun 369: 357-362.
75. Lin J, Cullen BR, (2007) Analysis of the interaction of primate retroviruses with the human RNA interference machinery. J Virol 81: 12218-12226.
76. Yeung ML, Yasunaga J, Bennasser Y, Dusetti N, Harris D, et al. (2008) Roles for microRNAs, miR-93 and miR-130b, and tumor protein 53-induced nuclear protein 1 tumor suppressor in cell growth dysregulation by human T-cell lymphotrophic virus 1. Cancer Res 68: 8976-8985.
77. Pichler K, Schneider G, Grassmann R, (2008) MicroRNA miR-146a and further oncogenesis-related cellular microRNAs are dysregulated in HTLV-1-transformed T lymphocytes. Retrovirology 5: 100.
78. Bellon M, Lepelletier Y, Hermine O, Nicot C, (2009) Deregulation of microRNA involved in hematopoiesis and the immune response in HTLV-I adult T-cell leukemia. Blood 113: 4914-4917.
79. Tomita M, Tanaka Y, Mori N, (2009) MicroRNA miR-146a is induced by HTLV-1 Tax and increases the growth of HTLV-1-infected T-cells. Int J Cancer.
80. Hobert O, (2008) Gene regulation by transcription factors and microRNAs. Science 319: 1785-1786.
81. Merkenschlager M, Wilson CB, (2008) RNAi and chromatin in T cell development and function. Curr Opin Immunol.
82. Jopling CL, Yi M, Lancaster AM, Lemon SM, Sarnow P, (2005) Modulation of hepatitis C virus RNA abundance by a liver-specific MicroRNA. Science 309: 1577-1581.
83. Huang J, Wang F, Argyris E, Chen K, Liang Z, et al. (2007) Cellular microRNAs contribute to HIV-1 latency in resting primary CD4+ T lymphocytes. Nat Med 13: 1241-1247.
84. Fazi F, Racanicchi S, Zardo G, Starnes LM, Mancini M, et al. (2007) Epigenetic silencing of the myelopoiesis regulator microRNA-223 by the AML1/ETO oncoprotein. Cancer Cell 12: 457-466.
85. Johnnidis JB, Harris MH, Wheeler RT, Stehling-Sun S, Lam MH, et al. (2008) Regulation of progenitor cell proliferation and granulocyte function by microRNA-223. Nature 451: 1125-1129.
86. de Vries W, Haasnoot J, van der Velden J, van Montfort T, Zorgdrager F, et al. (2008) Increased virus replication in mammalian cells by blocking intracellular innate defense responses. Gene Ther 15: 545-552.
87. Bennasser Y, Le SY, Benkirane M, Jeang KT, (2005) Evidence that HIV-1 encodes an siRNA and a suppressor of RNA silencing. Immunity 22: 607-619.